Alpha Pro Tech Ltd.

As of October 17, 2025, Alpha Pro Tech Ltd. is fairly valued with a P/E ratio of 12 and has underperformed the S&P 500, showing a year-to-date return of -12.67% compared to the index's 13.30%.

As of October 17, 2025, Alpha Pro Tech Ltd. is fairly valued with a P/E ratio of 12 and an EV to EBITDA of 8.34, but has underperformed the S&P 500 with a year-to-date return of -12.67%.

As of August 18, 2025, Alpha Pro Tech Ltd. is in a mildly bearish trend, with daily moving averages signaling bearishness, while weekly indicators show mild bullishness, and the stock has underperformed the S&P 500 with a return of -13.62% compared to the S&P's 17.14%.

As of June 30, 2025, Alpha Pro Tech Ltd. is fairly valued with a P/E ratio of 12 and has underperformed the S&P 500 year-to-date with a return of -8.88%, despite a three-year return of 19.31% that lags behind the index's 70.41%.

As of March 13, 2024, Alpha Pro Tech Ltd. is considered very attractive due to its undervalued status with a P/E ratio of 12, a Price to Book Value of 0.80, and an EV to EBITDA ratio of 8.34, making it a compelling investment opportunity despite recent stock performance lagging behind the S&P 500.

As of May 8, 2024, Alpha Pro Tech Ltd. shows a mildly bullish trend in the short term, supported by weekly indicators, but longer-term signals indicate a bearish sentiment, resulting in mixed overall outlook.

As of March 2022, the management team of Alpha Pro Tech Ltd. includes President and CEO Mr. Lloyd Hoffman, Senior VP Mr. Charles Montgomery, and several independent directors: Ms. Donna Millar, Mr. James Buchan, Mr. David Garcia, Mr. Russell Manock, and Dr. John Ritota. This team provides executive leadership and governance for the company.

Alpha Pro Tech Ltd. develops and markets disposable protective apparel and infection control products for various sectors, including medical and industrial. As of March 2025, it reported net sales of $14 million and a market cap of $49.32 million.

As of Jun 18, Alpha Pro Tech Ltd. has a market capitalization of 49.32 million, with net sales of 58.18 million and a net profit of 3.96 million over the latest four quarters. The balance sheet shows shareholder's funds of 62.23 million and total assets of 73.74 million.